Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV - Takeaways - MDSpire

Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV

  • By

  • Craig Cronin

  • Todd T Brown

  • Hsing-Yu Hsu

  • David C Samuels

  • Weiqun Tong

  • Sudipa Sarkar

  • Alison G Abraham

  • Jeremy J Martinson

  • Shehnaz K Hussain

  • Steven Wolinsky

  • Todd Hulgan

  • Jing Sun

  • January 3, 2026

  • 0 min

Share

  • 1

    Mitochondrial dysfunction is linked to higher diabetes mellitus prevalence in people with HIV compared to those without.

  • 2

    African mtDNA haplogroup L3 significantly increases the risk of developing diabetes in men with HIV.

  • 3

    Exposure to mitochondrial-toxic antiretroviral therapy, particularly D-drugs, is independently associated with increased diabetes risk.

  • 4

    The study analyzed 2598 men, including 1349 with HIV, to assess the relationship between mtDNA and diabetes incidence.

  • 5

    Understanding mitochondrial genetics may help address diabetes risk in the aging population of people living with HIV.

Original Source(s)

Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV

  • by Craig Cronin, Todd T Brown, Hsing-Yu Hsu, David C Samuels, Weiqun Tong, Sudipa Sarkar, Alison G Abraham, Jeremy J Martinson, Shehnaz K Hussain, Steven Wolinsky, Todd Hulgan, Jing Sun

  • January 3, 2026

Related Content

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Association of high-density lipoprotein cholesterol with the top 10 causes of death

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.